Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Correa

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
BMJ Open|May 19, 2023
Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplicationsJim Hu, Alec Zhu, Andrew Vickers, et al.
Urologic Oncology|August 7, 2024
The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registryCourtney Yong, James E Slaven, Zhenjie Wu, et al.
Cancers|July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative GroupMaxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Minerva Urology and Nephrology|April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
BMJ Open|May 19, 2023
Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplicationsJim Hu, Alec Zhu, Andrew Vickers, et al.
Urologic Oncology|August 7, 2024
The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registryCourtney Yong, James E Slaven, Zhenjie Wu, et al.
Cancers|July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative GroupMaxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Minerva Urology and Nephrology|April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Pageof 4